About Helix
Helix is a company based in San Francisco (United States) founded in 2015 by James Lu. It operates as a Data-as-a-Service, Professional Services, and HealthTech. Helix has raised $435 million across 4 funding rounds from investors including Illumina, Kleiner Perkins and NIH. Helix offers products and services including Helix Research Network, Helix Precision Pathway, Helix Diagnostics, Helix Genomic Advantage, and Helix GenoSphere. Helix operates in a competitive market with competitors including 23andMe, Benchling, Genuity Science, Counsyl and BioAge Labs, among others.
- Headquarter San Francisco, United States
- Founders James Lu
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Helix, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$435 M (USD)
in 4 rounds
-
Latest Funding Round
$50 M (USD), Series C
Jun 03, 2021
-
Investors
Illumina
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Helix
Helix offers a comprehensive portfolio of products and services, including Helix Research Network, Helix Precision Pathway, Helix Diagnostics, Helix Genomic Advantage, and Helix GenoSphere. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Genomic discoveries are accelerated for clinical impact.
Clinical decisions are enhanced with genomic insights.
Comprehensive genomic insights are provided for patients.
Healthcare costs are reduced for health plans.
Clinico-genomic cohorts are accessed for drug innovation.
Unlock access to complete
Unlock access to complete
Funding Insights of Helix
Helix has successfully raised a total of $435M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $50.0M
-
First Round
First Round
(28 Apr 2017)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Series C - Helix | Valuation | Warburg Pincus , DFJ Growth |
|
| Jul, 2020 | Amount | Grant - Helix | Valuation |
investors |
|
| Mar, 2018 | Amount | Series B - Helix | Valuation | DFJ Growth |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Helix
Helix has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Illumina, Kleiner Perkins and NIH. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Founded Year | Domain | Location | |
|
Investments are directed toward innovative technology startups by DFJ Growth.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in early-stage tech startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Helix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Helix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Helix Comparisons
Competitors of Helix
Helix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 23andMe, Benchling, Genuity Science, Counsyl and BioAge Labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
|
|
| domain | founded_year | HQ Location |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| domain | founded_year | HQ Location |
AI-based omics data analysis solutions are provided to researchers.
|
|
| domain | founded_year | HQ Location |
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Helix
Frequently Asked Questions about Helix
When was Helix founded?
Helix was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Helix located?
Helix is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Helix?
James Lu is the current CEO of Helix. They have also founded this company.
Is Helix a funded company?
Helix is a funded company, having raised a total of $435M across 4 funding rounds to date. The company's 1st funding round was a Series B of $200M, raised on Apr 28, 2017.
What does Helix do?
Helix is established as a leading enterprise genomics platform that transforms health and life-science organizations by leveraging genomic insights. Solutions are provided across sectors like health systems, providers, life sciences, and payers. Genomic intelligence is utilized to advance precision medicine, enhance patient care, and drive innovation in healthcare. Strategic growth is supported through expanded precision medicine capabilities, improved health outcomes, and diversified revenue streams. Healthcare economics are transformed by identifying high-risk populations and enabling targeted interventions.
Who are the top competitors of Helix?
Helix's top competitors include 23andMe, Benchling and BioAge Labs.
What products or services does Helix offer?
Helix offers Helix Research Network, Helix Precision Pathway, Helix Diagnostics, Helix Genomic Advantage, and Helix GenoSphere.
Who are Helix's investors?
Helix has 9 investors. Key investors include Illumina, Kleiner Perkins, NIH, Mayo Clinic, and Warburg Pincus.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.